Font Size

Estrogen and Progesterone Receptor Tests

Estrogen and Progesterone Receptor Tests

When a breast biopsy shows that cancer is present, other tests are used to find out which treatment will work the best.

Estrogen and progesterone receptor (ER/PR) tests identify whether hormones affect the way the cancer grows. The hormones estrogen and progesterone stimulate the growth of normal breast cells and some breast cancers. Breast cancer cells that lack these receptors (ER-negative and PR-negative cancers) are much less likely to respond to treatment with such medicines as tamoxifen or aromatase inhibitors. ER/PR-positive tumors have these receptors and are more likely to respond to treatment with tamoxifen or aromatase inhibitors.

The results of estrogen and progesterone receptor tests help your doctor decide whether to use hormone therapy to stop the cancer from growing.

Other tests that may be done at the same time include those for HER-2/neu and multi-gene tests, such as Oncotype DX and MammaPrint.


ByHealthwise Staff
Primary Medical ReviewerSarah Marshall, MD - Family Medicine
Specialist Medical ReviewerDouglas A. Stewart, MD - Medical Oncology
Last RevisedJune 28, 2011

eMedicineHealth Medical Reference from Healthwise

This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

To learn more visit

© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

Medical Dictionary